Abrdn World Healthcare Fund (NYSE:THW) Sees Large Decrease in Short Interest

Abrdn World Healthcare Fund (NYSE:THW) was the target of a large decline in short interest in July. As of July 31st, there was short interest totaling 50,789 shares, a decline of 71.5% from the July 15th total of 177,929 shares. Based on an average daily volume of 194,716 shares, the days-to-cover ratio is currently 0.3 days.

Abrdn World Healthcare Fund Price Performance

THW stock opened at $13.97 on Thursday. Abrdn World Healthcare Fund has a 12 month low of $10.84 and a 12 month high of $14.00. The firm has a 50 day simple moving average of $13.13 and a 200 day simple moving average of $12.69.

Abrdn World Healthcare Fund Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Monday, August 31st. Shareholders of record on Monday, August 24th will be issued a $0.1167 dividend. The ex-dividend date of this dividend is Monday, August 24th. This represents a c) annualized dividend and a dividend yield of 10.0%.

Institutional Investors Weigh In On Abrdn World Healthcare Fund

Several large investors have recently modified their holdings of the stock. Allied Private Wealth LLC acquired a new position in shares of Abrdn World Healthcare Fund in the 2nd quarter worth $27,000. Advisory Services Network LLC acquired a new stake in shares of Abrdn World Healthcare Fund during the third quarter worth $43,000. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Abrdn World Healthcare Fund during the second quarter worth $113,000. Mercer Global Advisors Inc. ADV purchased a new stake in shares of Abrdn World Healthcare Fund during the fourth quarter valued at $157,000. Finally, HighTower Advisors LLC purchased a new stake in shares of Abrdn World Healthcare Fund during the fourth quarter valued at $168,000.

About Abrdn World Healthcare Fund

Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.

The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.